Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 20, 2024Indian Journal of Public Health Research & Development

Post Marketing evaluation of Anti Snake Venom (ASV) administered as a standard treatment for snakebite. Experience from western India

View Full Paper
Ask AI
Bookmark
Share

Authors

DPDhirubhai C PatelVSVishwas SovaniNPNilesh Patel

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Patel et al. (2024) studied this question.

synapsesocial.com/papers/68e57d34b6db64358751c157https://doi.org/10.37506/9w4gpf62
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Evaluation of optimum dose of anti-snake venom required and its outcome based on severity of envenomation in snakebite case2024
  2. 2Snake Antivenom Therapy for Improving Outcome in Russell\'s Viper Envenomation [SAVIOR] – Comparing the Efficacy and Safety of 36 Hours Regimen vs 72 Hours Regimen: A Randomized Controlled Trial2026
  3. 3EPIDEMIOLOGICALAND CLINICAL PROFILE OF SNAKE BITE: A RETROSPECTIVE OBSERVATIONAL STUDY IN A TERTIARY CARE HOSPITAL, MANDYA2025
  4. 4Management of Venomous Snakebite beyond the Anti-snake Venoms2026
  5. 5Pharmacological Treatments and Adverse Reactions Following Snake Antivenom Therapy: A Collaborative Study by Healthcare Professionals in the Southernmost Region of Thailand2026